Home›Companies›Healthcare›Retham Technologies

Retham Technologies, Inc.

Develops diagnostic tests for hospitals and platelet products for researchers.

Updated Nov 9, 2026·Latest SEC filing Sep 11, 2026·Suggest an edit

About Retham Technologies

Retham Technologies is a private company based in Wauwatosa, Wisconsin, incorporated in 2024 in Delaware. It has reported $1,060,000 raised in one offering on Form D since September 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 28, 2026Sep 11, 2026$1,060,000of $1.5M target6$176KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Retham Technologies's Form D filed Sep 11, 2026.

AP
Anand Padmanabhan
Chief Science Officer & Chief Medical Officer, director
VS
Visuri Steven
Executive officer and director
CJ
Curtis Jones
VP Research & Innovation, director

Sources

  1. SECRetham Technologies, Inc. filing history
  2. CompanyRetham Technologies team